Dupilumab Linked to Improved Lung Function in Children with Asthma |
Journal Updates
eMediNexus Coverage from: 
Dupilumab Linked to Improved Lung Function in Children with Asthma

0 Read Comments                

Findings from a randomized study, presented at the CHEST conference, the annual meeting of the American College of Chest Physicians, revealed that children with uncontrolled, moderate-to-severe asthma had better lung function over the long term when they received treatment with dupilumab.In the study, use of add-on dupilumab in children ages 6-11 years appeared to improve forced expiratory volume in 1 second (FEV1) by a pre-bronchodilator average of 0.06 liters at week 2, compared to placebo (P=...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now